INFLUX — Influx Healthtech Cashflow Statement
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
Annual cashflow statement for Influx Healthtech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Net Income/Starting Line | 60.1 | 97.4 | 151 |
Depreciation | |||
Non-Cash Items | 0.049 | 0.093 | 2.66 |
Other Non-Cash Items | |||
Changes in Working Capital | -23.9 | -42.5 | -74.1 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | 37.4 | 64.3 | 98.1 |
Capital Expenditures | -28.6 | -45.2 | -92.6 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | 0 | 0 | 0.232 |
Other Investing Cash Flow | |||
Cash from Investing Activities | -28.6 | -45.2 | -92.3 |
Financing Cash Flow Items | -0.049 | -0.093 | -0.588 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 5.63 | 1.75 | -5.2 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 14.4 | 20.8 | 0.586 |